
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-18 | THOMPSON JANE J. | Director | Sale | 13.7K | $16.91 | $231K | 83.8K | View ↗ | |
| 2026-03-17 | 2026-03-18 | Schoen Kurt | See remarks | Purchase | 3,000 | $17.00 | $51K | 3,000 | View ↗ | |
| 2026-03-17 | 2026-03-18 | Cote John D. | Director | Purchase | 5,800 | $17.10 | $99K | 5,800 | View ↗ | |
| 2026-03-17 | 2026-03-18 | Knott Thomas R. | Director & See remarks | Purchase | 44.0K | $17.08 | $752K | 44.0K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $59.8M-85.8% | $420.6M+7.7% | $390.6M+3.2% | $378.5M+41.2% | $267.9M |
| Cost of sales | $31.1M-84.6% | $201.3M+10.9% | $181.5M+14.3% | $158.8M+29.0% | $123.1M |
| Gross profit | $28.7M-86.9% | $219.2M+4.9% | $209.1M-4.8% | $219.6M+51.6% | $144.8M |
| Selling, general and administrative expenses | $42.5M-61.9% | $111.6M+24.0% | $90.0M-14.1% | $104.7M+65.2% | $63.4M |
| (Loss) income from operations | -$13.7M-112.8% | $107.6M-9.6% | $119.1M | — | — |
| Revaluation of warrant liability | -$151.0M-57.4% | -$95.9M-1292.2% | $8.0M-57.5% | $18.9M+443.2% | $3.5M |
| Revaluation of earnout consideration liability | -$57.1M+25.2% | -$76.3M-636.0% | $14.2M-39.0% | $23.3M+143.7% | $9.6M |
| Change in fair value of derivative liability - convertible notes redemption make-whole provision | $0-100.0% | $425K+405.8% | -$139K-152.3% | $266K | $0 |
| Loss on remeasurement of TRA liability | -$3.5M | $0 | $0 | — | — |
| Interest income | $1.2M-73.5% | $4.6M-6.6% | $5.0M+298.5% | $1.2M | — |
| Interest expense | -$1.7M+91.6% | -$20.2M+26.7% | -$27.5M-28.8% | -$21.4M | — |
| Loss on extinguishment of debt | $0+100.0% | -$148K | $0 | $0 | — |
| Amortization of deferred financing costs | -$74K+93.3% | -$1.1M+31.3% | -$1.6M+33.4% | -$2.4M-42.6% | -$1.7M |
| Total other expense, net | -$212.1M-12.4% | -$188.6M-9278.3% | -$2.0M | — | — |
| (Loss) income before income taxes | -$225.8M-178.8% | -$81.0M-169.2% | $117.1M-14.0% | $136.2M | — |
| Income tax expense | -$39.0M-1684.5% | -$2.2M+52.0% | -$4.6M-4.5% | -$4.4M | — |
| (Loss) income before earnings in equity method investment | -$264.8M-218.4% | -$83.2M-173.9% | $112.5M | — | — |
| Earnings in equity method investment | $128.8M | $0 | $0 | — | — |
| Net (loss) income | -$136.0M-63.5% | -$83.2M-173.9% | $112.5M-14.6% | $131.8M | — |
| Net (loss) income attributable to redeemable non-controlling interests | $0+100.0% | -$29.4M-131.6% | $93.3M-17.6% | $113.2M | — |
| Net (loss) income attributable to GPGI, Inc. | -$136.0M-153.2% | -$53.7M-379.2% | $19.2M | — | — |
| Net (loss) income per share attributable to Class A common stockholders - basic (in dollars per share) | -$1K-0.8% | -$1K-218.4% | $1K | — | — |
| Net (loss) income per share attributable to Class A common stockholders - diluted (in dollars per share) | -$1K-0.8% | -$1K-227.1% | $960 | — | — |
| Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders - basic (in shares) | $110.52B+151.1% | $44.01B+135.8% | $18.66B | — | — |
| Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders - diluted (in shares) | $110.52B+151.1% | $44.01B+24.6% | $35.31B | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
GPGI (GPGI) Is Down 16.1% After Husky-Driven Q1 Loss And Mixed Segment Results - Has The Bull Case Changed?
Gpgi (GPGI) Q1 2026 Earnings Transcript
GPGI forecasts FY 2026 net sales $1.95B-$2.1B amid Husky order delays
GPGI, Inc. (GPGI) Q1 2026 Earnings Call Transcript